Hongzhi Li

The Sixth People's Hospital of Zhengzhou

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Compound screen identifies the small molecule Q34 as an inhibitor of SARS-CoV-2 infection”.

Compound screen identifies the small molecule Q34 as an inhibitor of SARS-CoV-2 infection

iScience(2021)10.1016/j.isci.2021.103684

N/A

0DataRank · unranked

5 citations

Gustavo Garcia, Mingzi Zhang, Cheng Wang, Hongzhi Li, Tao Zhou +4 more

Small molecule targeting of transcription-replication conflict for selective chemotherapy

Cell chemical biology(2023)10.1016/j.chembiol.2023.07.001

N/A

0DataRank · unranked

56 citations

Min Li, Caroline M. Li, Pouya Haratipour, Robert Lingeman, Jennifer Jossart +17 more

Repurposing Nilotinib as a Selective P38β Inhibitor in Hematopoietic Malignancies: Clinical Evidence and Mechanistic Insights

Journal of Clinical Haematology(2025)10.33696/haematology.6.067

N/A

0DataRank · unranked

1 citations

Jack Hsiang, Sangkil Nam, Hongzhi Li, Yate-Ching Yuan, Xiwei Wu +4 more